Boehringer Ingelheim (United States)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes”.
Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel +7 more
Eline Appelmans, Ramona Burress, Susan De Santi, Theresa Devins, Gregory Klein +14 more